Molecular Alterations Obtained by High-Throughput Methods in Multiple Myeloma Patients with Recurrent or Refractory to Heavy Treatment Regimens Could Guide Alternative Targeted Therapies

---

KUZU I., CENGİZ SEVAL G., YÜKSEL M., KAYGUSUZ G., DALVA K., ÖZCAN M., ...Daha Fazla

2nd AMP Europe Congress on Clinical Genomics - Beyond the Somatic Mutation, 11 - 13 Mayıs 2020, (Tam Metin Bildiri)

• Yayın Türü: Bildiri / Tam Metin Bildiri
• Ankara Üniversitesi Adresli: Evet